logo

For the Inventor, By the Inventor

Wayne, PA, United States of America

Robert L Morris

This inventor holds 19 USPTO granted patents. Top assignees: American Home Products Corporation, Rhone-Poulenc Rorer Pharmaceuticals Inc., Wyeth. Active years: 1979-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert L Morris. Retrieved from https://idiyas.com/inventor/robert-l-morris-ojysje2b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19

% Patents Active = 84.2

Average Co-Inventor Count = 3.9

ph-index = 8

Forward Citations = 229(Granted Patents)


Location History:

  • Devon, PA (US) (1979 - 1985)
  • Wayne, PA (US) (1990 - 2009)

Company Filing History:

goldMedal9 out of 1,567 
 
American Home Products Corporation
 patents
silverMedal4 out of 111 
 
Rhone-Poulenc Rorer Pharmaceuticals Inc.
 patents
bronzeMedal3 out of 1,309 
 
Wyeth
 patents
4. 1 out of 330 
 
Aventis Pharma Deutschland, Gmbh
 patents
5. 1 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents
6. 1 out of 109 
 
Rorer Pharmaceutical Corporation
 patents

Years Active: 1979-2009

Loading Chart...
19 patents (USPTO):Explore Patents
1. 7612075 - Substituted oxoazaheterocyclyl compounds (2009-11-03),
2. 7576215 - Quinolines and pharmaceutical compositions thereof (2009-08-18),
3. 7022733 - Substituted 2-phenyl benzofurans as estrogenic agents (2006-04-04),
4. 7005440 - Therapeutic uses of tri-aryl acid derivatives (2006-02-28),
5. 6774248 - Substituted 2-phenyl benzofurans as estrogenic agents (2004-08-10),
6. 5596020 - Amino bi- and tri-carbocyclic alkane bis-aryl squalene synthase (1997-01-21),
7. 5494918 - Multicyclic tertiary amine polyaromatic squalene syntase inhibitors (1996-02-27),
8. 5395846 - Amino Bi- and tri-carbocyclic aklane bis-aryl squalene synthase (1995-03-07),
9. 5385912 - Multicyclic tertiary amine polyaromatic squalene synthase inhibitors (1995-01-31),
10. 4946860 - Benzothiopyranyl derivatives as HMG-CoA reductase inhibitors (1990-08-07),
11. 4537968 - Thiophene derivatives with antisecretory activity (1985-08-27),
12. 4452985 - 2-Guanyl-4-(substituted phenyl) thiazole derivatives (1984-06-05),
13. 4301281 - 7,8-Dihydro-2,5 (1981-11-17),
14. 4255568 - 2H-Pyrimido[4,5-d][1,3]oxazine-2,4(1H)-dione derivatives (1981-03-10),
15. 4245094 - 5-Amino-2,8-dialkyl-7,8-dihydro-7-oxo-pyrido-[2,3-d]pyrimidine-6 (1981-01-13),

Title: Robert L Morris – Innovator in Pharmaceutical Compounds

Introduction

Robert L Morris, located in Wayne, PA, is a prolific inventor with a remarkable portfolio of 19 patents. His contributions primarily focus on innovative pharmaceutical compounds, particularly in the field of medicinal chemistry.

Latest Patents

Among his latest inventions, Morris has developed a series of substituted oxoazaheterocyclyl compounds aimed at inhibiting Factor Xa and Factor IIa. These compounds are crucial for pharmaceutical compositions designed to directly inhibit these factors, showcasing their potential in treating various medical conditions. Another notable patent involves quinolines that provide novel compounds useful for the treatment or inhibition of LXR mediated diseases, highlighting his commitment to addressing significant health issues.

Career Highlights

Robert L Morris has a rich professional background, having worked with prominent companies in the pharmaceutical industry, including American Home Products Corporation and Rhone-Poulenc Rorer Pharmaceuticals Inc. His experiences at these organizations have significantly contributed to his innovative capacity and expertise in developing breakthrough pharmaceutical solutions.

Collaborations

Throughout his career, Morris has collaborated with distinguished colleagues, including Anthony C Scotese and Arthur Attilio Santilli. These partnerships have enriched his work, fostering an environment of shared knowledge and innovation which has led to the successful development of various patents.

Conclusion

In conclusion, Robert L Morris exemplifies the spirit of innovation within the pharmaceutical realm. With his extensive patent portfolio and impactful collaborations, he continues to make significant strides in the field, contributing to advancements in medicinal chemistry and enhancing therapeutic options for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…